Healthcare workers left out of sick leave protections To view this email as a web page,
click here After nearly $1B in research funding, Moderna takes $1.5B coronavirus vaccine order from U.S. Alphabet’s Verily opens own lab to speed up COVID testing Healthcare workers lose out on COVID sick leave protections, federal watchdog says Parents are struggling with school and child care options amid COVID-19. Maven rolled out an online tool to help Researchers call out Gilead over diversity of remdesivir trials Kaiser Permanente announces $63M for contact tracing in California AstraZeneca bumps up vaccine deal with Brazil to $360M with more doses, licensing rights Healthcare roundup: BCBSRI expands no-cost Medicare Advantage benefits Biopharma roundup: IAVI, Wellcome push for global antibody access; Verily shoots for speedier testing with new lab, Thermo Fisher tech Featured Story | By Eric Sagonowsky Through its COVID-19 vaccine partnership with the U.S. government, Moderna picked up nearly $1 billion in research aid. Now, it's joining a long list of other companies to take a supply order from the federal government—locking up $1.5 billion in the process. read more |
| |
|---|
|
Top Stories By Ben Adams The buzzy life sciences company Verily is looking to speed up COVID testing with a new lab based at its native South San Francisco. read more By Tina Reed A new report from a federal watchdog finds a temporary rule issued by the Department of Labor has left many healthcare workers without COVID sick-leave protections passed by Congress back in March. read more By Heather Landi Working parents face touch decisions about how their children will soon return to school—whether it will be virtually or in person. Women and family health startup Maven developed an evidence-based tool to help patients assess the risks and benefits of different school and child care options. read more By Nick Paul Taylor Researchers have called for sponsors of COVID-19 clinical trials to run more diverse studies. The call follows an analysis of Gilead’s remdesivir clinical trials that found the studies “failed to provide equal representation of Black, Latinx and Native Americans.” read more By Tina Reed The non-profit integrated healthcare giant said the funding will be in the form of charitable grant funding to the Public Health Institute to create agile community health teams hired from communities disproportionately affected by COVID-19. read more By Kyle Blankenship In an effort to supercharge distribution of its vaccine hopeful, British drugmaker AstraZeneca has spanned the globe to ink a slew of national supply deals. Now, after inking a more limited pact in June, AstraZeneca and Brazil are ramping up their partnership to make even more doses of the shot. read more By Healthcare Staff Follow along with the latest COVID-19 news straight from the Fierce Healthcare team. read more By Eric Sagonowsky,Angus Liu,Kyle Blankenship,Conor Hale,Fraiser Kansteiner IAVI and Wellcome called for industry partnerships and new tech to ensure global access to antibody treatments. Verily set up a new lab to hustle along COVID testing. ANA Therapeutics got the OK to run human trials on a tapeworm med in COVID-19. SAB Biotherapeutics launched a polyclonal antibody phase 1. Plus, Fauci slammed Russia's newly-approved vaccine. read more |
|
